In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001681:Biological Assay; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D006168:Guinea Pigs; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D013329:Structure-Activity Relationship; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000494:pharmacology; D013931:Thromboxanes / Q000037:antagonists & inhibitors*; D014661:Vasoconstriction / Q000187:drug effects
D013931:Thromboxanes; D013928:Thromboxane A2; C037866:STA 2; C037868:ONO 11119; C037867:ONO 11105; C037869:ONO 11120